Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Topchoice Medical Corporation
  6. Financials
    600763   CNE000000MZ8

TOPCHOICE MEDICAL CORPORATION

(600763)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 15 22132 87588 66379 086--
Entreprise Value (EV)1 15 28532 77388 27578 02677 01775 743
P/E ratio 45,6x71,2x180x107x82,2x63,4x
Yield ---0,02%0,03%0,04%
Capitalization / Revenue 9,84x17,4x42,5x27,0x21,1x16,6x
EV / Revenue 9,89x17,3x42,3x26,7x20,6x15,9x
EV / EBITDA 28,9x45,5x114x71,8x55,4x43,0x
Price to Book 11,6x18,4x41,2x27,5x20,6x15,6x
Nbr of stocks (in thousands) 320 640320 640320 640320 640--
Reference price (CNY) 47,5103277247247247
Announcement Date 03/28/201904/23/202004/09/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 1 5461 8942 0882 9273 7424 766
EBITDA1 5307207721 0871 3901 762
Operating profit (EBIT)1 4396346791 0021 3121 702
Operating Margin 28,4%33,5%32,5%34,2%35,1%35,7%
Pre-Tax Profit (EBT)1 4396336801 0031 3161 710
Net income1 3324634937369621 247
Net margin 21,5%24,4%23,6%25,1%25,7%26,2%
EPS2 1,041,441,542,293,003,89
Dividend per Share2 ---0,060,080,10
Announcement Date 03/28/201904/23/202004/09/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3
Net sales1 453574473193545714
EBITDA ------
Operating profit (EBIT)1 149243113--318
Operating Margin 33,0%42,3%23,8%--44,5%
Pre-Tax Profit (EBT)1 149242113--317
Net income1 11319263,4--251
Net margin 25,0%33,4%13,4%--35,1%
EPS2 0,350,600,19--0,78
Dividend per Share ------
Announcement Date 08/01/201910/29/201904/23/202004/23/202008/03/202010/26/2020
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 64,4-----
Net Cash position1 -1033891 0592 0693 343
Leverage (Debt / EBITDA) 0,12x-0,14x-0,50x-0,98x-1,49x-1,90x
Free Cash Flow1 ---5929371 306
ROE (Net Profit / Equities) 28,7%29,9%24,4%26,8%26,3%25,4%
Shareholders' equity1 1 1591 5502 0202 7423 6554 915
ROA (Net Profit / Asset) 16,9%-17,1%19,8%20,2%18,9%
Assets1 1 964-2 8773 7264 7746 596
Book Value Per Share2 4,105,576,718,9811,915,8
Cash Flow per Share2 1,462,022,212,913,614,66
Capex1 241126166244250288
Capex / Sales 15,6%6,64%7,94%8,34%6,67%6,04%
Announcement Date 03/28/201904/23/202004/09/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 79 085 856 000
Capitalization (USD) 12 290 336 296
Net sales (CNY) 2 087 864 860
Net sales (USD) 324 504 308
Number of employees 4 118
Sales / Employee (CNY) 507 009
Sales / Employee (USD) 78 801
Free-Float 58,3%
Free-Float capitalization (CNY) 46 145 121 022
Free-Float capitalization (USD) 7 171 181 858
Avg. Exchange 20 sessions (CNY) 1 496 179 393
Avg. Exchange 20 sessions (USD) 232 542 186
Average Daily Capital Traded 1,9%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA